Healthy adult
Conditions
Interventions
None listed
Sponsors
KAGOME CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (PICO) Participant: Adults without illness (excluding pregnant women , women who plan to become pregnant, and lactating women) Intervention: Oral intake of foods containing SGS (regardless of the form of intake) Comparison: Oral intake of placebo foods that do not contain SGS, or no intervention Outcome: Maintenance and improvement of cognitive function at the final evaluation point Study design: Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi-randomized controlled parallel trials (qRCT-P), quasirandomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials (Language) Eligibility is not restricted by language.
Exclusion criteria
Exclusion criteria: Studies that do not aim to evaluate cognitive function, and studies that assess the safety of excessive intake by having subjects consume large amounts of SGS in a short period, are excluded due to differing objectives.Exclude proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indicators of processing speed within cognitive function | — |
Secondary
| Measure | Time frame |
|---|---|
| Indicators of cognitive functions other than processing speed | — |
Countries
Japan
Contacts
Public ContactShohei Satomi
KAGOME CO., LTD. Diet & Well-being Research Institute
Outcome results
None listed